Cefpodoxime Proxetil structure
|
Common Name | Cefpodoxime Proxetil | ||
---|---|---|---|---|
CAS Number | 87239-81-4 | Molecular Weight | 557.597 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C21H27N5O9S2 | Melting Point | 111-113°C | |
MSDS | N/A | Flash Point | N/A |
Use of Cefpodoxime ProxetilCefpodoxime Proxetil is a first oral and broad spectrum antibiotic that belongs to the third generation of cephalosporin. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis[1]. |
Name | cefpodoxime proxetil |
---|---|
Synonym | More Synonyms |
Description | Cefpodoxime Proxetil is a first oral and broad spectrum antibiotic that belongs to the third generation of cephalosporin. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis[1]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Melting Point | 111-113°C |
Molecular Formula | C21H27N5O9S2 |
Molecular Weight | 557.597 |
Exact Mass | 557.125000 |
PSA | 234.51000 |
LogP | 2.17 |
Index of Refraction | 1.671 |
Storage condition | -20?C Freezer |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: WO2004/48387 A1, ; Page 7-8 ; |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Rodriguez, Juan C.; Hernandez, Ricardo; Gonzalez, Maritza; Rodriguez, Zalua; Tolon, Blanca; Velez, Herman; Valdes, Barbara; Lopez, Miguel A.; Fini, Adamo Farmaco, 2003 , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
~% Cefpodoxime Proxetil CAS#:87239-81-4 |
Literature: Farmaco, , vol. 58, # 5 p. 363 - 369 |
Precursor 9 | |
---|---|
DownStream 0 |
HS Code | 2941905990 |
---|
A multicentric, open label, randomised, postmarketing efficacy study comparing multidose of lincomycin hydrochloride capsule 500 mg with multidose cefpodoxime proxetil tablet 200 mg in patients with tonsillitis, sinusitis.
J. Indian Med. Assoc. 110(8) , 580-3, (2012) Tonsillitis causes considerable short and medium term morbidity, and can be recurrent. Sinusitis can be acute (less than 4 weeks), subacute (4-8 weeks) or chronic (8 weeks or more). To study the compa... |
|
Ionic liquids as superior solvents for headspace gas chromatography of residual solvents with very low vapor pressure, relevant for pharmaceutical final dosage forms.
J. Chromatogr. A. 1216(32) , 6020-3, (2009) 1-n-Butyl-3-methylimidazolium dimethyl phosphate (BMIM DMP) was identified as the most suitable ionic liquid as solvent for the headspace gas chromatographic analysis of solvents with very low vapor p... |
|
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
Pharmacoeconomics 10(2) , 164-78, (1996) Cefpodoxime proxetil is an orally administered prodrug which is converted in vivo to the third generation cephalosporin cefpodoxime. Cefpodoxime has a similar spectrum of antibacterial activity to the... |
R-3763 |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)- |
Cefodox |
JP,USP |
Cefpodoxime proxetil |
1-isopropoxycarbonyloxyethyl (6R,7R)-7-[2-(2-aminothiazol-4-yl)-2-(Z)-(methoxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylate |
Orelox |
CS-807 |
1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Cefpodoxime 1-(Isopropoxycarbonyloxy)ethyl ester |
Podomexef |
BANAN |
UNII:2TB00A1Z7N |
[6R-[6a,7b(Z)]]-7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester |
MFCD00864906 |
1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
1-(Isopropoxycarbonyloxy)ethyl (6R,7R)-7-[2-(2-Amino-4-thiazolyl)-(Z)-2-(methoxyimino)acetamido]-3-methoxymethyl-3-cephem-4-carboxylate |
1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester |
cefprodoxime proxetil |
1-{[(1-Methylethoxy)carbonyl]oxy}ethyl-(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylat |
Otreon |
cefpodoxime-proxetil |
1-{[(1-methylethoxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)- |
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Vantin |